Last updated: 2026-09-04 23:39:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Rafael Holdings, Inc. (RFL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $2,57, with a market capitalisation of $130,52M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,12 to $3,96. This page covers its latest market performance, valuation, price trends and company information.
$130,52M | |
$2,49 | |
$400,02 | |
$0,15 | |
$2,47 | |
134,89K | |
-- | |
-- | |
$3,96 | |
$1,12 | |
-- | |
-- |
Rafael Holdings, Inc. (RFL) is trading at $2,62 in after-hours trading as of 2026-09-04 23:37:00, up 6,03% ($0,15) from the regular-session close of $2,47.
After-hours trading shows how investors are pricing RFL after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Rafael Holdings, Inc. (RFL) moved from $2,56 to $2,57, representing a gain of 0,39% ($0,01).
The stock traded between $2,49 and $2,71 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 131,97 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 51,1%
RFL is currently trading at $2,57, placing it 51,1% of the way from its 52-week low of $1,12 to its 52-week high of $3,96. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 23 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Rafael Holdings, Inc. (RFL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.